Richard Li has wide experience in advising public and private companies and investment funds on cross-border business transactions with primary focus on life sciences industry, including mergers and acquisitions, joint ventures, strategic collaborations, licensing, co-promotion and distribution arrangements.
Mr. Li regularly advises pharmaceutical, biotechnology, medical device, food and cosmetic companies on complex regulatory and policy matters, including preclinical and clinical studies, product registration, manufacturing authorization, bidding, pricing, reimbursement, promotion and distribution, labeling, advertising, patient assistance programs, donations, product withdrawal and recall, pharmacovigilance, technology transfer and regulatory due diligence. Mr. Li also advises food and drug companies and industry associations on their advocacy efforts, such as preparing policy papers and comments on the draft regulations and policies issued by Chinese agencies.
